Friday, December 31, 2010

Project HOPE Board of Directors – Diabetes Presentation

October, 2010 Project HOPE was kind enough to let me present some of my findings from A Journey for HOPE to the board. The following presentation depicted at a high-level, the purpose, process, and outcome of 5 months and 10 countries worth of research. Although there were substantial themes of findings that held consistent from one country to the next – I tried to convey the varied nature of the condition and vulnerability to cultural norms and perceptions.

I included what I called “the faces of diabetes” to help portray various archetypes of patients I met during my travels.


Below is a selected diagram that depicts the three frameworks I used throughout my research (another version included in the first blog post). What I’ve found is that taking a population based, or traditional public health, viewpoint alone is not sufficient for diabetes. Unlike infectious diseases, NCDs are constantly changing within the population and each individual (whether at risk, diagnosed, or managing the condition). A lifecycle approach is needed to understand the prevention required at the individual level as diabetes relief efforts help stop the progression across the spectrum of risk to compliance. The systemic perspective (what care is provided, where, and by whom) is vital to understand disruptive models in diabetes and chronic disease treatment that can creatively use resources available to produce the best outcome at both individual and population levels.


Finally, and most importantly, is Project HOPE’s role in providing global diabetes relief. I proposed Project HOPE serve as an unbiased intersection of public and private interests that works towards the betterment of patients and communities. I believe Project HOPE can maximize its impact by focusing on gaps in current public and private offerings and helping them align incentives to increase the overall value to the beneficiaries.
Funding this effort will require a broad portfolio of donors, many of which are non-traditional healthcare donors such as Pepsi, Nike, or Subway.


Since the completion of my field research with Project HOPE, I have been contacted by a number of physicians, nurses, dietitians, and experts worldwide. Thank you wholeheartedly for the immense dedication and passion you are pouring into your communities. The following are several articles and presentations resulting from this research this fall:


A Silent Epidemic - Southeast Asia Globe (PDF Version)


Haas Healthcare Association Presentation – Project HOPE & Diabetes

The final findings and recommendations for Project HOPE will be shared when approved. I hope this research works to help and benefit all who work locally and globally for children, families, communities, and nations who struggle with diabetes.

The Africa Diabetes Leadership Forum: Johannesburg Sept 30-Oct 1, 2010

At the referral of several of my interviewees, Novo Nordisk and the World Diabetes Foundation graciously invited me to their Africa Diabetes Leadership Forum hosted in Johannesburg this September. The goal of the event was to bring light to critical needs and best practices on diabetes programs and policies in Africa. In addition, nearly every health Minister of Health of the African region was present to recognize the importance of diabetes in their national priorities and agenda.

 

One of the first speakers was the First Lady of the Republic of South Africa, Bongi Ngema. She first began with a personal story talking about lifestyle change. Cooking oil must be used in moderation. Gardens must be planted. People must change their behavior. She then continued to address her dedication to women with diabetes in their families and gestational diabetes as a priority for the country and region.


Professor Pierre Lefébvre later conducted a very moving speech that simplified many of the concepts and difficulties I had seen throughout my research. He compared diabetes to a tsunami. What we are seeing now is the very splashes of a wave that is going to rupture the health of our communities. He presented a model for thinking about success as it pertains to diabetes programs. E= MC2 or Excellence = Money/Manpower X Committment2. Commitment is critical to using the resources available to us to achieve our goal.


Lise Kingo, the Executive VP and Chief of Staff of Novo Nordisk went on to describe the corporate involvement in addressing diabetes needs through the World Diabetes Foundation (WDF). Novo Nordisk’s extensive work in diabetes since 1923 has proven that diabetes “hits the poorest countries the hardest.” It prevents children from going to school, disables parents and grandparents, and kills friends and neighbors through lack of detection and availability of treatment. Ms. Kingo described Novo Nordisk’s “triple bottom line” that measures overall company performance along three axes: financials, social responsibility, and environmental responsibility. Their programs through the WDF are funding a substantial portion of all diabetes programs globally addressing affordability, health system strengthening, the most vulnerable of patients, and advocacy/awareness campaigns at the country level.

The goal for the forum and outcome is to establish sustainable and LOCALLY owned programs and policies. The WDF has helped countries all over the world with leadership forums (NY, Moscow, Beijing, Johannesburg, Dubai) identify a holistic approach with partnerships and metrics to execute on a vision. She ended with a lovely African proverb, “if you want to walk fast, walk alone; if you want to walk far, walk together.”


Prof. Jean Claude Mbanya, President of the IDF, continued with some additional points specific to Africa. In his perspective, the young working population is the most vulnerable and likely to develop Type 2 at rates never before seen in Africa. The second are children with Type 1 diabetes – for them this is a death sentence without resources, education, and affordability. Jean Claude also described diabetes as an inherent threat to many current infectious disease efforts. This was an interesting take and was built on later by Knut Lönnroth and Frank Mwangemi who discussed TB at the World Health Organization and HIV/noncommunicable disease integration respectively. We also went through a detailed “lessons learned” from HIV in the region from Miriam Rabkin.

George Alleyne of PAHO (Pan American Health Organization) discussed “knocking on an open political door” and described what are traditionally referred to as noncommunicable diseases (NCDs) as the neglected chronic diseases (NCD) since they were originally neglected from the Millennium Development Goals. This “dual disease burden” of infectious disease and chronic disease must be addressed through scoped 1. Programs, 2. Funding, and 3. Impact (public health, financial, reach, etc.). Incentives MUST align to accomplish long-term goals. George reinforced the need to generate Activity with IMPACT vs. Activity with intention… a route which has been pursued by many who have fought to get the resources and programs on foot to date.

From what I could discern, each country would have to develop at a minimum (1) a public health and financial business case for diabetes and NCDs, (2) agreement and alignment of public-private incentives and goals, and (3) definitive goals and metrics to which success would be evaluated. Ideally, each country would also start with a clear baseline of data indicating the size, location, and areas of greatest need.


A pleasant surprise during the day was Derek Yach, the Director of Global Health Policy at Pepsi. A South African native having spent the majority of his career at the WHO, Derek is committed to reshaping Pepsi as a sign of hope for the future of humanity vs. a threat to humanity. “Every 30 seconds a limb is lost to diabetes,” he describes. His team is working with the company’s R&D to cut billions of calories in Pepsi’s food portfolio. The food industry has enormous power to shape how and what we eat – and this will benefit millions of people globally if they are able to successfully make healthy foods that people want to eat. Even starting with Pepsi Max in developing countries might help – diet sodas in general are very difficult to find and at times more expensive as the demand is low.

In the evening Tshepo Musese, a South African musician and actor with Type 1 diabetes, shared a moving performance that highlighted some of his experiences including: weight loss, fear of needles, family challenges, affordability. 

The second day of the forum was dedicated to best practices sharing which included a number of my previous interviewees including Dr. Eva Njenga, Atieno Jalango, Dr. Maina, Mrs. Eva Muchemi, Dr. Francois Bonnici, and Professor Rheeder. Segments included examples of programs or policies across the following:
  • General awareness education
  • Exercise
  • Nutrition
  • Training healthcare workers
  • Early detection / screening
  • Treatment protocol / coordination
  • Patient empowerment / compliance
  • Quality of resources / data
  • Complications prevention and management


At the end of the forum the general consensus was that the event was enormously successful. Africa is on its way to developing national and a larger regional strategy for diabetes and other NCDs (both noncommunicable diseases and previously neglected chronic diseases).

IDF has published a Summary Report for the forum online.

South Africa Findings: A Dual-Burden of Disease

South Africa hosts a number of Africa’s leading experts on diabetes care in Cape Town, Johannesburg, and many dispersed in the less-urban centers of the country. Compared to Kenya, South Africa has far more resources for diabetes patients including more health coverage, system infrastructure, academic research, and a very established national Diabetes Association South Africa (Diabetes ZA). What I would learn is that my first stop, Johannesburg, would soon be the diabetes focus point for the African region with an upcoming IDF/WDF supported Africa Diabetes Leadership Forum in September 2010.

The Diabetes ZA Executive Manager, Leigh-Ann Bailie, cites that diabetes kills as many people annually as HIV/AIDS in South Africa. A country with eleven national languages and even more used in practice creates challenges for national efforts. With only about 2 physicians per 10,000 patients, resource constraints are a large concern. Additionally, the dichotomy of the “have” and “have-nots” in South Africa create two sub-groups of communities with diabetes. The programs and mechanisms used to reach, educate, and treat them maybe dramatically different. Despite considerable changes in the South African society over the past 20 years, racial tension and segregation must still be considered delicately.

Stefan Lawson, Project HOPE’s country lead in South Africa, took some time to update me on their efforts more broadly and current concepts in diabetes. Establishing a community-based clinic or hub for various activities – education, detection, treatment, etc. would be a potential program to get started. Similar to Kenya, many low-income families believe vegetables or fruits are out of reach. A garden or cooking classes could help empower women in the communities to change the way they think about providing affordable meals for their families. Stefan also cited the need for fitness opportunities in urban areas – where safety is largely a concern and gyms are reserved for the middle/upper classes.

Diet Remains a Challenge

Professor Rheeder of the University of Pretoria took some time with Stefan and I to lay out a number of issues, the first and foremost – diet. Similar to Kenya, the traditional low-income diet in South Africa is porridge or cornmeal “pop”. Dietary awareness programs are few and with even fewer examples of success to replicate more broadly. However, he notes, general awareness about diabetes and the link to obesity is “ok”. The growth of fastfood chains like KFC and others have been steady in the past 10 years. Still, the choices are limited and many lack access to patient education programs to help them make healthy decisions.

Access to Detection & Treatment Limited

In the short-term, curative medicine is the single greatest need for patients with or at risk of developing diabetes. Most patients also pay out of pocket and cannot afford either medication, glucose monitoring or both. Prof. Rheeder emphasized the importance of focusing on the curative capability with respect to the peripheral areas (i.e. complications) associated with longer-term cases.

However, in order to address the right population further programs need to be established to detect those with and at high risk for diabetes. The University of Pretoria, under Prof. Rheeder’s leadership, has established a mobile diabetes diagnostic bus to “share” resources and medical expertise across regions. This is very similar to Project HOPE’s partnership with United Healthcare in New Mexico. The South African bus spends about 3 weeks in a given location, either hospital parking lot or corporate area) to increase access and awareness for diabetes diagnosis.

Diabetes ZA is also heavily involved in doing discounted testing for patients in need. However, they don’t get enough donations to do free testing for low-income or unmotivated individuals. Some corporate efforts will sponsor nurses for a few hours a day, but these barely make enough money to cover the cost of strips – about 300 Rand (US $43) per 50 pack.

One of my favorite tools that they are testing, however, is the “patient passport.” Assuming the patient is literate, the patient passport could be a powerful mechanism to empower patients and promote them to take charge of their diabetes. Each passport has educational pieces up front (e.g. two pages on physiology), information on short-term and long-term complications, a checklist of what you should have performed in a clinic, and custom pages dedicated to “my story”. Similar to Mexico, these personalized pages document progress using the stop-light red, yellow, green methodology.

Healthcare Expertise & Capacity Issues

Healthcare expertise and capacity to treat populations with diabetes is undoubtedly better than most regions of Africa. However, South Africa has significant potential to develop and demonstrate success with capacity expansion efforts that could be translated to the rest of the region.

Professor Willie Mollentze of the University Free Sate in Bloemfontein, ZA describes his experience working in the second poorest province in the country. With a population of 2.6 million, Bloemfontein has about 98,000 people with diabetes, 48,000 of which were registered just this past year. In addition to this surprising growth, clinics dedicated for diabetes patients are overwhelmed with workload. He sees 80-100 patients a day and has been working to creatively identify ways to reach more patients with even the fewest resources (people, medications, and diagnostic/monitoring technologies) available.

Dr. Francois Bonnici has been a driving force behind capacity expansion efforts focusing on children with Type 1 diabetes at the Red Cross Children’s Hospital in Cape Town. As one of the most eminent global leaders in diabetes, Dr. Bonnici has also worked to establish a number of the diabetes associations and national programs and policies all over Africa.


Serving now as the only wholly dedicated children’s diabetes center in the southern hemisphere, the Red Cross Children’s Hospital treats about 750 active patients under the leadership of Lyn Starck, a diabetes educator and pediatric nurse. Over the years she notes an increase in children with Type 2 diabetes and the sentiment that the onset of Type 1 diabetes is occurring younger and younger in their community. Lyn reflects on a number of familiar challenges:  glucose monitoring strips are too expensive, nurses “waste” time spent on admin responsibilities and paperwork, language barriers for patients in various regions, and lack of skilled healthcare professionals. She also mentioned a number of national efforts to improve healthcare infrastructure in South Africa – primary care rebuilt only at the expense of tertiary care. These shortcomings unfortunately have huge implications for diabetes patients who rely on nearly all levels of the healthcare system and infrastructure.

Dr. Bonnici and Lyn stress, “you have to empower the nurses.” Working with groups like DESSA (Diabetes Education Society of South Africa) to establish a curriculum to train diabetes educators in South Africa is critical. More importantly for the long-term, getting this role acknowledged by the government medical system will create a pipeline and legitimate career path nurses can pursue focused on diabetes. It seems that despite years of work to create this role and curriculum, there are more politics behind the scene that need to be addressed.

Creating a Vision for Diabetes Care in South Africa

I was profoundly moved by my time spent with Dr. Bonnici in Cape Town. After decades of working in this space, his perspective and experience is incomparable. First, he emphasizes, we need a vision. In business terms, the return-on-investment (ROI) will be different for the short and long terms. In the short-term we need to focus on complications of diabetes such as footcare and eye care to prevent amputation, blindness, and dialysis. These will help prevent expensive and life-deteriorating conditions for millions of patients in South Africa. In the long term, prevention is the key focus.  Early detection, awareness campaigns, and elementary school healthy habits programs are all strong candidates for prevention, but only time will tell how effective they can be.

The billion-dollar question is still on the table - is lifestyle change an attainable goal? For the future of South Africa and larger global health - we truly hope so. Dr. Bonnici’s comments around lifestyle change reminded me of my conversation with Dr. Ashraf Ismail from Joint Commission International in Dubai relating to safety – “safety is a product of culture, not processes.” Lifestyle change will happen when eating healthy is “smart” and cultural norms refuse to accept other behavior. This is very similar to the evolution seen with smoking in the US over the past 20 years.

So how do we get here? Targeting obesity and multiple risk factors is a start. Improving opportunities for biking and physical activity in public (similar to the city gyms in Brazil or China) is another. However, Dr. Bonnici stresses that the true key to lifestyle change and the future of diabetes is women empowerment. Empowering female heads of households and nurses to educate and shift norms of daily living is critical to the long-term success of any diabetes program.

Dr. Silver Bahandeka, VP of the International Diabetes Federation for Africa, describes his vision of programs as three-fold in order of priority:
  1. Patient-focused diabetes education: nutrition, exercise, screening, management, compliance with complications
  2. Juvenile diabetes programs: access to insulin, education programs for family and educator. 
  3. Medical capacity building: physician education, diabetes educator nurse training programs

Interestingly these focus first on patient/individual, then community/collective, then systemic/infrastructure needs in that order. As the champion for the Africa Diabetes Leadership Forum in September, Dr. Bahandeka has been a strong driver in promoting diabetes programs and policies at a national level. Working with Ministers of Health across the region, he has advocated for increased funding for diabetes despite many ministries small or previously allocated budgets.

In this journey, many will be looking for leaders in the region as role models for replicable efforts. South Africa and Cameroon, in Dr. Bahandeka’s opinion, have made great advances in their diabetes efforts with both strong programs and policies. Several interviewees in South Africa agreed that the national policies are very good but have been poor in implementation.

Translating vision to reality is going to be the largest challenge for countries in the African region. Top-down efforts may be a harder model for success - many noteworthy programs are led by one, very dedicated leader who has built it from the ground up. Incentives (financial or otherwise) that align with the national vision but promote ownership and self-starter initiatives may prove most successful in the coming years. Looking farther ahead, succession planning of these efforts will be critical to make them sustainable (and ideally self-sustainable) over time.

In the meantime, the Africa Diabetes Leadership Forum will be an invigorating impetus to getting a foothold on the right path. 

Kenya Findings: Africa's Shocking Glimpse of Diabetes

My gut reaction when asked to go to Africa for diabetes work was that this would resemble the earlier stages of what I had seen progressing in the Middle East, Americas, or most likely Asia. I was shocked by how wrong I was. Nairobi presented to me a reminder of how varied the needs in diabetes are among regions, communities, and lifestyles globally. Africa is developing a different breed of diabetes I have seen in other regions, largely due to significant differences in diet and cultural perceptions than the rest of the world. The rates for diabetes, especially Type 2, were much higher than I had anticipated and growing quite rapidly with little education and healthcare infrastructure to treat non-infectious diseases.

About 3.5% of Kenya’s population has diabetes – totaling about 520,000 patients in 2010. While the needs for Type 1 patients in Africa did resemble that noted in many other countries, although with much fewer resources, the largest surprise in Africa was the demographic of the typical Type 2 patient. Many Type 2 patients are triggered by familiar issues: adoption of Western lifestyles, poor diet, and lack of exercise

However, many Type 2 patients in Kenya are NOT overweight, but underweight and simultaneously malnourished. The first clinic that cited this finding literally made me almost fall off of my chair in both shock and fear. This will require (1) significant locally-based research into why this is the case (there has been none to date due to lack of funding) and (2) custom programs in awareness and screening efforts that will be dramatically different from other regions globally. I dedicated myself to try and understand the medical perceptions for why this is the case, despite the lack of research, and have outlined a few hypotheses below based on the interviews.

HIV/AIDS and Africa

It is difficult to relate to health development in Africa without recognizing the role HIV/AIDS development work and efforts have had on individual communities and the larger region. The first thing that was apparent is the disproportionate amount of healthcare funding devoted to HIV in Africa. Tents for testing and ongoing treatment were evident at nearly every hospital and many community centers. Many interviews I conducted discussed the “overfunding” of HIV in the region and sometimes unethical use of funds or programs to use up assigned budgets. This was indeed surprising, but important to hear reiterated from varied government, corporate, and non-profit voices. Based on population alone, Africa receives significantly more health development funding than any other region. It is imperative that the purpose and use of these funds are re-evaluated to maximize impact to the community and its health.


While many HIV/AIDS programs have been very successful in terms of increasing awareness and diagnosis rates, it has not addressed a lot of the personal/family embarrassment issues, not to mention the need to balance both privacy and community openness. Everyone is aware of the “signs” for someone who has HIV and it seems on the lookout for family, friends, neighbors. For example, weight loss is typically a flag for the diagnosis of HIV or use of antiretrovirals. Historically, weight has been a sign of wealth, status and stability in most regions in Africa. This has significant implications for individuals with both Type 1 and Type 2 diabetes: Type 1 showing loss of weight at the onset of diabetes and Type 2 losing weight to control his/her symptoms, both of which could be perceived by onlookers as HIV. Therefore, many resist losing weight under any circumstances and ingest low-cost, high-calorie diets that are often very low in nutrients.

Additionally, many of the HIV efforts having succeeded in their purpose fail to dis-incentivize individuals from contracting HIV/AIDS. Although extensive prevention and educational programs exist, management is the main focus of HIV efforts. In Africa, HIV/AIDS is addressed essentially like a chronic disease. What was hopeful to me, is there could be a million “lessons learned” from HIV programs in Africa over the years that could be translated to traditional chronic diseases – like diabetes. Despite a number of models that have worked well (community diagnosis/monitoring, local women initiatives, country-wide annual testing campaigns), programs have not quite figured out the prevention side, where the long-term return-on-investment lies. One of the largest challenges results from lack of financial incentives: if you contract HIV in much of Africa, there are virtually no financial consequences. This is contrasted with the now growing diabetes rates – causing significant trauma on family and household economics. One of the very common quotes to hear from newly diagnosed patients is “I’d rather have HIV than have diabetes” referring to the lack of diabetes support in comparison to plentiful HIV relief efforts that make it easy to cope with the disease.

“I’d rather have HIV than have diabetes” – a common patient perspective in Kenya

Finally, there is a growing intersection of diabetes, HIV, and TB in Africa. The co-morbidity of HIV and Type 2 diabetes is seen as a long-term side-effect of many of the antiretroviral treatments. Wearing down the metabolic system over time, antiretroviral regimens are hypothesized to contribute to increased rates of diabetes regardless of weight, diet, and exercise lifestyle considerations. TB/diabetes co-morbidities are also noticed in Africa where TB has shown to put patients at higher risk for developing Type 2 diabetes. I believe that the large majority of development funds focused on diabetes in Africa will begin in the next 2-3 years with joint HIV/TB programs that either already exist or use existing funding. While this may address some of the problem, funding focus will have to evolve to include a new portfolio for diabetes in the coming years to address urgent needs for Type 1, gestational diabetes, and the emerging Type 2.

“Pop” and Tribal Mindset: Diet in Kenya

Few families are able to afford a regularly healthy diet in Kenya. Unlike much of Asia, the Middle East, or South America, healthy foods can be scarce and financially out of reach for many households. The Kenyan diet is traditionally comprised of “pop,” a cornmeal based porridge consumed as the main meal daily in the late afternoon (e.g. around 4pm). Githi Theuri, a Nairobi based nutritionist in a cardiologist office, described the diet as a resemblance of the earlier “tribal” mindset. Many tribes ate only one meal a day in the late afternoon with game meat about once a week. Fruits? Vegetables? These were not perceived as important factors in a traditional diet and, many believe, a root cause of the growing Type 2 diabetes prevalence.

I spent my weekend in Kenya on the border of Kenya and Tanzania with a Maasai tribe learning about their lifestyle and perceptions as one of the regions only preserved tribal cultures. Similar to what Githi illustrated, they eat one meal a day of grains and kill one cow a week to feed their living community: about 25-30 people. Cows are the only currency used by Maasai and almost anything that is produced by them is reused for food or shelter including blood, milk, meat, hides, bones, etc. Dairy milk with fresh cow’s blood is considered the equivalent to a Maasai energy drink, if you will. In recent years the government has encouraged Maasai to adopt “modern” technologies such as currency or bank accounts, but the community has largely refused.


Despite the vast and fertile land available in this region, farming is not pursued due to lack of agriculture education and irrigation technologies.  In addition to confirming what I had learned in Nairobi about Kenyan diet, the Maasai helped me understand what I heard repeated in interviews as the “tribal mindset” to which affects urban perceptions on family, money, and priorities. This could not be more opposite than the Western consumer-driven culture; tribal mindset incorporates a desire to only work as hard as needed to survive. Not much value is placed on surpluses of “things” or money, and there may be little trust in the longevity of both.

Therefore, few families have a lot of extra income to spare and the concept of setting aside finances for healthcare is unknown. Diabetes will sink a boat in tribal mindset – both resulting from diet and financial impact. Simultaneously, the modern or urbanized form of a tribal diet is a large plate of French fries smothered in ketchup, mayonnaise, or your condiment of choice. I became a loyal client of the Java Coffee house near the hospital district in Nairobi and witnessed this with even their highest-end of customers. French fries! Kenyan diet has evolved but remains a mainly carbohydrate and protein-based diet with few variety in food and nutrients.

Challenges for Diabetes in Kenya

The primary and most urgent challenge for diabetes in Kenya is the need to increase resources for children with Type 1 diabetes. Similar to India, lack of resources for families with Type 1 children is a death sentence. Insulin and community-based educational programs for families and educators are essential. The Kenya Diabetes Management and Information Center (DMI) in Nairobi has been a leader in addressing this need with funding primarily from Novo Nordisk’s World Diabetes Foundation. The financial burden of Type 1 diabetes is not manageable for most Kenyans and the center focuses now on sponsoring insulin and monitoring for 90 children and a youth camp which was attended this year by 70 or so patients and family members.


Although they are the first to acknowledge this is a drop in the bucket. I met with Mrs. Eva Muchemi, the head of DMI, who described the challenges in securing this funding on an ongoing basis and future plans to expand to training of healthcare workers throughout the healthcare system in Kenya. 80% of Kenya’s population is rural creating significant infrastructure and resource challenges for patients in non-urban areas. Through their persistence, DMI’s efforts and coordination with the emerging Diabetes Association in the region are admirably leading the way for patients in Africa.

Gestational diabetes has been explored as a focus due to its higher rates than seen in other countries. This could result from diet during pregnancy and is often overlooked by both pregnant mothers and health professionals if untested. One of the largest issues with gestational diabetes is that without treatment the impact – a significantly larger baby – is often celebrated as a good and healthy outcome considering traditional perceptions of health and weight. Later resurgence of Type 2 diabetes is not prevented or addressed and can create a number of health risks for the mother and child years later. A recent initiative from the MOH has required all pregnant mothers to be tested for gestational diabetes, however successful implementation of this effort is still pending. Despite a positive push in the right directly, many hospitals don’t have the equipment, processes, or expertise to execute standardized testing.

Type 2 diabetes is growing quite rapidly in urban, but also rural areas. I met with Dr. Rene Kiamba and Jotham Nkonge, the J&J Manager Sub-Saharan Africa and LifeScan Sales Manager  to learn more about their programs in diabetes management. J&J has demonstrated substantial leadership in training health professionals and increasing educational programs for patients with diabetes globally. They described financial limitations as the largest inhibitor to effective treatment – as all care for diabetes is out of pocket. They also illustrated the emergency of a “new” Type 2 diabetes seen in underweight or malnourished patients. This creates more challenges as health professionals struggle to standardize risk signs for testing and diagnosis with limited resources.

Africa & the Skinny Type 2 Diabetic

How are patients developing non-obesity driven Type 2 diabetes in Africa? All research indicates that abdominal fat, diet, and exercise are the key contributors to the progression of Type 2 diabetes. Dr. Eva Njenga, one of the founding members of DMI and currently the lead of their board of directors, described her experience treating patients with diabetes for decades in Nairobi and the Kenyan region. Her hypothesis, and a common perception among leading physicians in Kenya, is the carbohydrate-rich diet essentially wears out the pancreas and triggers insulin resistance. Of course, there is no research to validate this making it difficult to stand behind any prevention-based effort.


Jean Suren, an American diabetes care and training nurse in Nairobi, has reiterated Dr. Njenga’s sentiments with the need to focus on training and capacity building in physicians, but also nurses in the region. Disagreements over the training curriculum that should be adopted in Kenya, due to lack of research and its unique challenges and limitations, have slowed the progress for nation-wide objectives and programs. DMI and the Diabetes Association in development have focused on this as a critical first-step in fighting diabetes in Kenya. Still, the “new” skinny Type 2 diabetic continues to perplex health professionals and contributes to the total growth of diabetes in the region.

Community-Based Efforts

In addition to children-focused programs at DMI, educational campaigns to the community for both awareness are screening are critical and in development. Dr. Maina, the Noncommunicable Disease head for the Ministry of Health of Kenya, described this as the focal point of their effort in the ministry of health. How they plan to achieve this is by targeting the district hospital level in Kenya for training of healthcare professionals and distribution of posters raising awareness on diabetes in 12 of the most common languages. Similar to India, Kenya has 50-100 languages creating another layer of challenges for nationwide programs.
I also see a great potential for agriculture-based programs at the community level. Anything that supports families or communities in producing healthy food options economically will help prevent Type 2 diabetes. Also basic education on cooking affordable but healthy meals with available resources would boost family eating habits without impacting finances. However, many families are simply concerned about getting enough food so efforts should be focused primarily on increasing resources in addition to learning how to use existing ones better.

Finally, national surveys and research that provide accurate data on the disease burden, contributing risk factors, and effective treatments are essential, but costly. A reoccurring challenge in many countries, these efforts are vital to establish metrics and objectives for programs but are hard to fund as they compete with programs that directly impact patients (such as insulin relief and healthcare worker training).

As the MOH works to increase capacity for diabetes awareness, detection, and treatment nationally – it will benefit from the strengthening of organizations like the Kenya Diabetes Association and International Diabetes Association’s presence in Africa. Recognition of the unique challenges from the patient, physician, clinic, and larger community-wide perspectives will help Kenya develop more programs to better address the needs of diabetes patients going forward. 

DMI Office in Nairobi